| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2004;43:156.)
© 2004 American Heart Association, Inc.
Rapid Communication |
From Department of Cardiovascular Medicine (K.I., Y.H., T.K., Y.K., H.S., A.T.), Kyushu University Graduate School of Medical Sciences, Fukuoka, and the Department of Cell Pharmacology (K.K.), Nagoya University Graduate School of Medicine, Nagoya, Japan.
Correspondence to Dr Yoshitaka Hirooka, Fellow of the Council for HBPR, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan. E-mail hyoshi{at}cardiol.med.kyushu-u.ac.jp
Central nervous system mechanisms are involved in hypertension caused by chronic inhibition of nitric oxide (NO) synthesis. Chronic inhibition of NO synthesis might also activate the Rho/Rho-kinase pathway in the vasculature. We recently demonstrated that activation of the Rho/Rho-kinase pathway in the nucleus tractus solitarii (NTS) contributes to hypertensive mechanisms in spontaneously hypertensive rats. The aim of the present study was to determine whether activation of this pathway also contributes to neurogenic hypertensive mechanisms caused by chronic NO synthesis inhibition. The NO synthase inhibitor N
-nitro-L-arginine methyl ester (L-NAME) was administered to Wistar-Kyoto rats in their drinking water (1 mg/mL) for 2 weeks. Bilateral microinjection of Y-27632, a specific Rho-kinase inhibitor, into the NTS elicited decreases in arterial pressure, heart rate, and renal sympathetic nerve activity in control rats and L-NAMEtreated rats. The magnitude of the decrease, however, was significantly greater in L-NAMEtreated than in control rats. In another group of rats, the specific Rho-kinase inhibitor, Y-27632, was administered intracisternally for 2 weeks with a mini-osmotic pump from the beginning of treatment with L-NAME. Y-27632 co-treatment significantly attenuated the increase in arterial pressure. Furthermore, the expression level of membranous RhoA and phosphorylation of the target proteins of Rho-kinase, the ERM (ezrin, radixin, moesin) family members, was significantly greater in L-NAMEtreated rats than in control rats. These results indicate that activation of the Rho/Rho-kinase pathway in the NTS contributes to neurogenic hypertension caused by chronic NO synthase inhibition.
Key Words: nitric oxide blood pressure sympathetic nervous system hypertension brain
This article has been cited by other articles:
![]() |
C. S. Thompson-Torgerson, L. A. Holowatz, N. A. Flavahan, and W. Larry Kenney Rho kinase-mediated local cold-induced cutaneous vasoconstriction is augmented in aged human skin Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H30 - H36. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Thompson-Torgerson, L. A. Holowatz, N. A. Flavahan, and W. L. Kenney Cold-induced cutaneous vasoconstriction is mediated by Rho kinase in vivo in human skin Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1700 - H1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Zucker Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure Hypertension, December 1, 2006; 48(6): 1005 - 1011. [Full Text] [PDF] |
||||
![]() |
K. Ito, Y. Hirooka, Y. Kimura, Y. Sagara, and K. Sunagawa Ovariectomy Augments Hypertension Through Rho-Kinase Activation in the Brain Stem in Female Spontaneously Hypertensive Rats Hypertension, October 1, 2006; 48(4): 651 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Seasholtz, J. Wessel, F. Rao, B. K. Rana, S. Khandrika, B. P. Kennedy, E. O. Lillie, M. G. Ziegler, D. W. Smith, N. J. Schork, et al. Rho Kinase Polymorphism Influences Blood Pressure and Systemic Vascular Resistance in Human Twins: Role of Heredity Hypertension, May 1, 2006; 47(5): 937 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, Y. Hirooka, N. Hori, Y. Kimura, Y. Sagara, H. Shimokawa, A. Takeshita, and K. Sunagawa Inhibition of Rho-Kinase in the Nucleus Tractus Solitarius Enhances Glutamate Sensitivity in Rats Hypertension, August 1, 2005; 46(2): 360 - 365. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kimura, Y. Hirooka, Y. Sagara, K. Ito, T. Kishi, H. Shimokawa, A. Takeshita, and K. Sunagawa Overexpression of Inducible Nitric Oxide Synthase in Rostral Ventrolateral Medulla Causes Hypertension and Sympathoexcitation via an Increase in Oxidative Stress Circ. Res., February 4, 2005; 96(2): 252 - 260. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lonergan, A. G. Teschemacher, D. Y. Hwang, K.-S. Kim, A. E. Pickering, and S. Kasparov Targeting brain stem centers of cardiovascular control using adenoviral vectors: impact of promoters on transgene expression Physiol Genomics, January 20, 2005; 20(2): 165 - 172. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Lee, R. C. Webb, and L. Jin Hypertension and RhoA/Rho-Kinase Signaling in the Vasculature: Highlights From the Recent Literature Hypertension, December 1, 2004; 44(6): 796 - 799. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ito, Y. Hirooka, Y. Sagara, Y. Kimura, K. Kaibuchi, H. Shimokawa, A. Takeshita, and K. Sunagawa Inhibition of Rho-Kinase in the Brainstem Augments Baroreflex Control of Heart Rate in Rats Hypertension, October 1, 2004; 44(4): 478 - 483. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |